What is it about?

Drug metabolism enzymes as biomarker of disease susceptibility in Parkinson's disease.

Featured Image

Why is it important?

First report of defects in drug metabolism in Parkinson's disease patients.

Read the Original

This page is a summary of: Xenobiotic metabolism in Parkinson's disease, Neurology, July 1989, Wolters Kluwer Health,
DOI: 10.1212/wnl.39.7.883.
You can read the full text:



Be the first to contribute to this page